LathyrolCAS# 34420-19-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 34420-19-4 | SDF | Download SDF |
PubChem ID | 5281376 | Appearance | White powder |
Formula | C20H30O4 | M.Wt | 334.45 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Solubility | DMSO : ≥ 100 mg/mL (299.00 mM) *"≥" means soluble, but saturation unknown. | ||
SMILES | CC1CC2(C(C1O)C(C(=C)CCC3C(C3(C)C)C=C(C2=O)C)O)O | ||
Standard InChIKey | SDBITTRHSROXCY-OKFBFAQVSA-N | ||
Standard InChI | InChI=1S/C20H30O4/c1-10-6-7-13-14(19(13,4)5)8-11(2)18(23)20(24)9-12(3)17(22)15(20)16(10)21/h8,12-17,21-22,24H,1,6-7,9H2,2-5H3/b11-8+/t12-,13-,14+,15-,16+,17-,20+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Lathyrol diterpenes is a modulator of P-glycoprotein dependent multidrug resistance, and is used for cancer treatment. |
Targets | P-gp |
In vitro | Lathyrol diterpenes as modulators of p-glycoprotein dependent multidrug resistance: structure-activity relationship studies on euphorbia factor l3 derivatives.[Pubmed: 25856545]J Med Chem. 2015 May 14;58(9):3720-38.Five series of 37 new acylate and epoxide derivatives (3-39) of Euphorbia factor L3, a Lathyrol diterpene isolated from Euphorbia lathyris, were designed by modifying the hydroxyl moiety of C-3, C-5, or C-15. Chemoreversal effects of the acylates on multidrug resistance (MDR) were evaluated in breast cancer multidrug-resistant MCF-7/ADR cells that overexpress P-glycoprotein (P-gp).
|
Lathyrol Dilution Calculator
Lathyrol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.99 mL | 14.9499 mL | 29.8998 mL | 59.7997 mL | 74.7496 mL |
5 mM | 0.598 mL | 2.99 mL | 5.98 mL | 11.9599 mL | 14.9499 mL |
10 mM | 0.299 mL | 1.495 mL | 2.99 mL | 5.98 mL | 7.475 mL |
50 mM | 0.0598 mL | 0.299 mL | 0.598 mL | 1.196 mL | 1.495 mL |
100 mM | 0.0299 mL | 0.1495 mL | 0.299 mL | 0.598 mL | 0.7475 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Lathyrol is a natural product, and is used for cancer treatment.
In Vitro:Lathyrol exhibits reversal effects in MCF-7/ADR breast cancer cell lines in vitro[1].
References:
[1]. Jiao W, et al. Lathyrol diterpenes as modulators of P-glycoprotein dependent multidrug resistance: structure-activity relationship studies on Euphorbia factor L3 derivatives. J Med Chem. 2015 May 14;58(9):3720-38.
- 8-Chloroadenosine
Catalog No.:BCC7935
CAS No.:34408-14-5
- Boc-Lys(Z)-OSu
Catalog No.:BCC3418
CAS No.:34404-36-9
- H-D-Lys(Z)-OH
Catalog No.:BCC2678
CAS No.:34404-32-5
- Boc-D-Glu-OBzl
Catalog No.:BCC3394
CAS No.:34404-30-3
- Betamipron
Catalog No.:BCC8876
CAS No.:3440-28-6
- H-D-Pro-OH
Catalog No.:BCC3023
CAS No.:344-25-2
- N-Demethyl-alpha-obscurine
Catalog No.:BCN7362
CAS No.:34399-44-5
- Isovallesiachotamine
Catalog No.:BCN3549
CAS No.:34384-71-9
- Acebutolol HCl
Catalog No.:BCC4322
CAS No.:34381-68-5
- CP-673451
Catalog No.:BCC4981
CAS No.:343787-29-1
- Ginsenoside Ro
Catalog No.:BCN5937
CAS No.:34367-04-9
- Isoapetalic acid
Catalog No.:BCN5276
CAS No.:34366-34-2
- 2,3-dihydrosciadopitysin
Catalog No.:BCN4034
CAS No.:34421-19-7
- Lyoniside
Catalog No.:BCN5277
CAS No.:34425-25-7
- Ikshusterol
Catalog No.:BCN5278
CAS No.:34427-61-7
- Ligularine
Catalog No.:BCN2090
CAS No.:34429-54-4
- Tirandamycin A
Catalog No.:BCN1861
CAS No.:34429-70-4
- Prudomestin
Catalog No.:BCN5279
CAS No.:3443-28-5
- Alpha-Onocerin diacetate
Catalog No.:BCN6700
CAS No.:34434-99-6
- Amycomycin
Catalog No.:BCN1824
CAS No.:344362-08-9
- Nortrachelogenin
Catalog No.:BCN5280
CAS No.:34444-37-6
- PJ34 hydrochloride
Catalog No.:BCC2210
CAS No.:344458-15-7
- PJ34
Catalog No.:BCC1865
CAS No.:344458-19-1
- 17-ODYA
Catalog No.:BCC6717
CAS No.:34450-18-5
Lathyrol diterpenes as modulators of P-glycoprotein dependent multidrug resistance: structure-activity relationship studies on Euphorbia factor L3 derivatives.[Pubmed:25856545]
J Med Chem. 2015 May 14;58(9):3720-38.
Five series of 37 new acylate and epoxide derivatives (3-39) of Euphorbia factor L3, a Lathyrol diterpene isolated from Euphorbia lathyris, were designed by modifying the hydroxyl moiety of C-3, C-5, or C-15. Chemoreversal effects of the acylates on multidrug resistance (MDR) were evaluated in breast cancer multidrug-resistant MCF-7/ADR cells that overexpress P-glycoprotein (P-gp). Eight derivatives exhibited greater chemoreversal ability than verapamil (VRP) against adriamycin (ADR) resistance. Compounds 19 and 25 exhibited 4.8 and 4.0 times, respectively, more effective reversal ability than VRP against ADR resistance. To determine the key characteristics of Euphorbia factor L3 derivatives that contribute to MDR reversal, we conducted a structure-activity relationship study of these compounds. The simulation studies indicated different possible mechanisms and revealed the important influence of hydrophobic interactions and hydrogen bonds in the flexible cavity of P-gp.